Key result
A 31-year-old pregnant patient with severe pulmonary arterial hypertension underwent cesarean delivery followed by percutaneous right ventricular assist device placement.
Why the study?
Physiologic changes of pregnancy are poorly tolerated in patients with pulmonary arterial hypertension, and peripartum maternal mortality is high.
Case Report (n=1)
Answers are grounded in this paper and cite their sources.
This case report highlights the potential utility of percutaneous right ventricular assist devices for managing severe pulmonary arterial hypertension during the high-risk peripartum period.
Physiologic changes of pregnancy are poorly tolerated in patients with pulmonary arterial hypertension (PAH), and peripartum maternal mortality is high. We present a case of a 31-year-old G3P0020 patient at 35 weeks' gestation with severe World Health Organization group I PAH who underwent cesarean delivery followed by percutaneous right ventricular assist device placement. Risks and benefits of the mode of delivery, neuraxial versus general anesthesia, and mechanical circulatory support are reviewed.
No takes yet. Share an insight, caveat, or question.
Thomas et al. (2023) conducted a case report in Severe World Health Organization group I pulmonary arterial hypertension (n=1). Percutaneous right ventricular assist device placement after cesarean delivery was evaluated. A 31-year-old pregnant patient with severe pulmonary arterial hypertension underwent cesarean delivery followed by percutaneous right ventricular assist device placement.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: